Skip to main content
Search

Pharmaceutical Research

An Official Journal of the American Association of Pharmaceutical Scientists

AAPS logo

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others.

Pharmaceutical Research publishes twelve issues a year.

Pharmaceutical Research:

  • Presents research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval  
  • Covers pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics and more 
  • Is an official journal of the American Association of Pharmaceutical Scientists
  • Provides excellent author service: 97% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Tonglei Li
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.580 (2021)
Impact factor
4.914 (2021)
Five year impact factor
7 days
Submission to first decision (Median)
932,054 (2021)
Downloads

Latest issue

Volume 40

Issue 2, February 2023

Latest articles

This journal has 478 open access articles
View all articles

Journal updates

  • The AAPS Journals Make Use of Portable Peer Review

    If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals (AAPS Open, The AAPS Journal, AAPSPharmSciTech, or Pharmaceutical Research), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, allows us to share, between the portfolio, previous peer review comments and reviewer names, subject to approval of all parties. This can help speed up the assessment process, should the editor choose to make a decision on the basis of the comments and revision. Interested?  Email us with the name of the journal to which you are going to submit. Note: Portable peer review is opt-in only, available at the authors’ preference, and the reviewer identities and comments will only be shared between offices, not to the author.

  • AAPS Pharmaceutical Research Meritorious Manuscript Award

    AAPS Pharmaceutical Research Meritorious Manuscript Award Recognizing outstanding achievement in the pharmaceutical sciences as demonstrated by the author(s) in the quality and originality of a manuscript published in Pharmaceutical Research.  Watch the video here.

    Awardee/Corresponding Author: Dennis Douroumis, Ph.D., University of Greenwich Co-Authors: Nicolaos Scoutaris, Ph.D. and Steven A. Ross, Ph.D.

  • Featured article

    Repurposing of kinase inhibitors for treatment of COVID-19
    There are three major needs that have yet to be met for effective management of COVID19 disease: 1) anti-viral therapies that limit viral transmission, cell entry, and replication, 2) therapies that attenuate the non-productive immune response and thus decrease end-organ damage, and 3) therapies that have an anti-fibrotic effect in patients with ARDS and thus decrease long-term sequelae of disease. Read the article above for the full review and proposal.

  • Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger

    AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.


View all updates

Societies, partners and affiliations

For authors

Submission guidelines
Manuscript editing services
Ethics & disclosures
Open Access fees and funding
Contact the journal
Calls for papers
Submit manuscript

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more

Explore

Online first articles
Volumes and issues
Collections
Sign up for alerts

About this journal

Electronic ISSN
1573-904X
Print ISSN
0724-8741
Abstracted and indexed in
  1. AGRICOLA
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  7. CLOCKSS
  8. CNKI
  9. CNPIEC
  10. Chemical Abstracts Service (CAS)
  11. Chimica
  12. Current Contents/ Life Sciences
  13. Dimensions
  14. EBSCO Academic Search
  15. EBSCO Biomedical Reference Collection
  16. EBSCO Discovery Service
  17. EBSCO MasterFILE
  18. EBSCO STM Source
  19. EMBASE
  20. Google Scholar
  21. INSPEC
  22. Japanese Science and Technology Agency (JST)
  23. Journal Citation Reports/Science Edition
  24. Medline
  25. Meta
  26. Naver
  27. OCLC WorldCat Discovery Service
  28. Pathway Studio
  29. Portico
  30. ProQuest-ExLibris Primo
  31. ProQuest-ExLibris Summon
  32. Reaxys
  33. SCImago
  34. SCOPUS
  35. Science Citation Index
  36. Science Citation Index Expanded (SCIE)
  37. TD Net Discovery Service
  38. UGC-CARE List (India)
  39. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature